DECLARATION BY THE PERSON RESPONSIBLE FOR THE INTERIM FINANCIAL REPORT STATUTORY AUDITORS’ REPORT ON THE INTERIM FINANCIAL STATEMENTS MANAGEMENT REPORT HALF-YEAR FINANCIAL STATEMENTS CONDENSED INTERIM CONSOLIDATED Notes to the consolidated income statement 22 AXWAY - 2021 INTERIM FINANCIAL REPORT www.axway.com Revenue Note 4 Revenue by business line 4.1 The breakdown by business line is presented in Note 3.1, Revenue by business line. International operations 4.2 The breakdown by region is presented in Note 3.2, Revenue by region. Employee costs Note 5 Breakdown of employee costs 5.1. (in thousands of euros) H1 2021 H1 2020 Salaries 78,864 78,431 Social security contributions 18,505 19,493 Research tax credits -4,494 -4,854 Employee profit-sharing 152 363 Net expense for post employment and similar benefit obligations 168 35 Total employee costs 93,195 93,469 Employee costs accounted for 67.3% of H1 2021 revenue, comparable with 2020 (68.4%). Research tax credits totalled €4.5 million in H1 2020, down €0.4 million. Research & Development expenditure expensed in H1 2021 totalled €29 million, compared to €30.4 million in H1 2020 (see Section “First-half 2021 results”). Workforce 5.2 Number of employees at 30 June H1 2021 H1 2020 France 473 471 International 1,323 1,414 Total 1,796 1,885 At 30 June 2021, Axway had 1,796 employees (26% in France and 74% internationally), down 89 on 31 December 2020 which was comparable to 30 June 2020. This decrease mainly concerns Research and development employees following completion of the investment phase that was necessary to ramp up the Amplify offering. Average number of employees H1 2021 H1 2020 France 478 468 International 1,365 1,401 Total 1,843 1,869
RkJQdWJsaXNoZXIy NzMxNTcx